These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25637438)

  • 1. Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics.
    Zeilhofer HU; Ralvenius WT; Acuña MA
    Adv Pharmacol; 2015; 73():71-96. PubMed ID: 25637438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of pathological pain through specific spinal GABAA receptor subtypes.
    Knabl J; Witschi R; Hösl K; Reinold H; Zeilhofer UB; Ahmadi S; Brockhaus J; Sergejeva M; Hess A; Brune K; Fritschy JM; Rudolph U; Möhler H; Zeilhofer HU
    Nature; 2008 Jan; 451(7176):330-4. PubMed ID: 18202657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.
    Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU
    Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
    Knabl J; Zeilhofer UB; Crestani F; Rudolph U; Zeilhofer HU
    Pain; 2009 Feb; 141(3):233-238. PubMed ID: 19091469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype-selective GABAA receptor mimetics--novel antihyperalgesic agents?
    Zeilhofer HU; Witschi R; Hösl K
    J Mol Med (Berl); 2009 May; 87(5):465-9. PubMed ID: 19259638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of GABA(A) receptor subtypes as analgesic targets.
    Mirza NR; Munro G
    Drug News Perspect; 2010; 23(6):351-60. PubMed ID: 20697602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites.
    Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU
    Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABA(A) [corrected] receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function.
    Hofmann M; Kordás KS; Gravius A; Bölcskei K; Parsons CG; Dekundy A; Danysz W; Dézsi L; Wittko-Schneider IM; Sághy K; Gyertyán I; Horváth C
    Behav Pharmacol; 2012 Dec; 23(8):790-801. PubMed ID: 23075708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.
    Besson M; Daali Y; Di Lio A; Dayer P; Zeilhofer HU; Desmeules J
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):192-7. PubMed ID: 23006671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists.
    Zeilhofer HU; Möhler H; Di Lio A
    Trends Pharmacol Sci; 2009 Aug; 30(8):397-402. PubMed ID: 19616317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral functions of GABAA receptor subtypes--the Zurich experience.
    Crestani F; Rudolph U
    Adv Pharmacol; 2015; 72():37-51. PubMed ID: 25600366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(A) receptor modulation: potential to deliver novel pain medicines?
    Munro G; Hansen RR; Mirza NR
    Eur J Pharmacol; 2013 Sep; 716(1-3):17-23. PubMed ID: 23500203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets.
    Munro G; Ahring PK; Mirza NR
    Trends Pharmacol Sci; 2009 Sep; 30(9):453-9. PubMed ID: 19729210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice.
    Asiedu MN; Mejia G; Ossipov MK; Malan TP; Kaila K; Price TJ
    J Pain; 2012 Jun; 13(6):546-54. PubMed ID: 22537560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
    Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
    Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.